We are live on ! Find out more
BSX icon

Boston Scientific
BSX

409 hedge funds and large institutions have $11B invested in Boston Scientific in 2013 Q2 according to their latest regulatory filings, with 409 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more call options, than puts

Call options by funds: $30.6M | Put options by funds: $13.9M

87.6% more ownership

Funds ownership: 0% → 87.6% (+88%)

Holders
409
Holders Change
+409
Holders Change %
–
% of All Funds
13.35%
Holding in Top 10
12
Holding in Top 10 Change
+12
Holding in Top 10 Change %
% of All Funds
0.39%
New
409
Increased
–
Reduced
–
Closed
–
Calls
$30.6M
Puts
$13.9M
Net Calls
+$16.7M
Net Calls Change
+$16.7M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
101
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$13.2M +$12.1M +1,424,919 New
State of Wisconsin Investment Board
102
State of Wisconsin Investment Board
Wisconsin
$13.2M +$12M +1,418,880 New
U
103
UBS
Switzerland
$12.5M +$11.4M +1,347,715 New
GH
104
GAM Holding
Switzerland
$12.1M +$11.1M +1,303,161 New
AGA
105
Altrinsic Global Advisors
Connecticut
$11.4M +$10.4M +1,229,700 New
SAM
106
Shell Asset Management
Netherlands
$10.7M +$9.76M +1,150,869 New
Jacobs Levy Equity Management
107
Jacobs Levy Equity Management
New Jersey
$10.5M +$9.58M +1,129,900 New
Caisse de Depot et Placement du Quebec (CDPQ)
108
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$9.57M +$8.76M +1,032,400 New
VOYA Investment Management
109
VOYA Investment Management
Georgia
$9.38M +$8.59M +1,012,357 New
Balyasny Asset Management
110
Balyasny Asset Management
Illinois
$9.31M +$8.52M +1,003,880 New
CCM
111
Camber Capital Management
Massachusetts
$9.27M +$8.48M +1,000,000 New
DFO
112
Duquesne Family Office
New York
$9.27M +$8.48M +1,000,000 New
Chevy Chase Trust
113
Chevy Chase Trust
Maryland
$8.77M +$8.02M +945,616 New
CCP
114
Clough Capital Partners
Massachusetts
$8.76M +$8.01M +944,600 New
Aviva
115
Aviva
United Kingdom
$8.66M +$7.93M +934,727 New
PI
116
PineBridge Investments
New York
$8.23M +$7.53M +888,002 New
BCIM
117
British Columbia Investment Management
British Columbia, Canada
$8.22M +$7.52M +886,417 New
Royal Bank of Canada
118
Royal Bank of Canada
Ontario, Canada
$7.89M +$7.22M +851,008 New
MLICM
119
Metropolitan Life Insurance Company (MetLife)
New York
$7.87M +$7.2M +848,653 New
SG Americas Securities
120
SG Americas Securities
New York
$7.59M +$6.95M +819,031 New
Citigroup
121
Citigroup
New York
$7.48M +$6.84M +806,817 New
Retirement Systems of Alabama
122
Retirement Systems of Alabama
Alabama
$7.44M +$6.8M +802,254 New
V
123
ValueWorks
New York
$7.42M +$6.79M +800,810 New
CFG
124
Cambridge Financial Group
Ohio
$7.22M +$5.61M +661,329 New
Macquarie Group
125
Macquarie Group
Australia
$7.16M +$6.55M +771,995 New
3 4
5
6 7

BSX Hedge Fund Activity: Q2 2013 in Review

409 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2013, worth a combined $11B.

Buyers outnumbered sellers: 409 funds opened new BSX positions and 0 closed out — a net gain of 409 holders — while 0 added to existing stakes and 0 trimmed.

  • 409 institutional investors held Boston Scientific (BSX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $11B of Boston Scientific stock for Q2 2013.
  • 409 funds opened new Boston Scientific positions in Q2 2013 and 0 closed out, a net change of +409 holders.

Based on aggregated 13F filings for Q2 2013.